Altered plasma levels of cytokines in patients with ischemic heart disease

被引:56
|
作者
Tashiro, H
Shimokawa, H
Yamamoto, K
Momohara, M
Tada, H
Takeshita, A
机构
[1] KYUSHU UNIV,SCH MED,RES INST ANGIOCARDIOL,HIGASHI KU,FUKUOKA 81282,JAPAN
[2] KYUSHU UNIV,SCH MED,CARDIOVASC CLIN,HIGASHI KU,FUKUOKA 81282,JAPAN
关键词
cytokine; ischemic heart disease; unstable angina; macrophage colony-stimulating factor; transforming growth factor-beta;
D O I
10.1097/00019501-199703000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cytokines play an important role in mediating inflammatory-proliCerative responses, including atherosclerosis, Alterations in the plasma levels of cytokines in patients with ischemic heart disease (IHD) remain to be examined, Objective To examine the possible alterations in the plasma levels of cytokines in patients with IHD and in controls, Methods Thirty-one patients with IHD and 16 controls were studied, The cytokines measured in our study included interleukin-6, macrophage-colony-stimulating factor (MCSF), transforming growth factor-beta (TGF-beta), and seven other major cytokines, The measurements were performed by using an enzyme-linked immunosorbent assay method, Results The MCSF levels were significantly higher in patients with IHD than they were in controls (P< 0.01), whereas the TGF-beta levels were significantly lower in patients with IHD than they were in controls (P< 0.01). Moreover, the levels of MCSF and those of TGF-beta were correlated negatively (P< 0.05), The interleukin-6 levels tended to be higher in patients with unstable angina, The plasma levels of other cytokines were below the detection levels in most cases, Conclusions Results from studies in vitro suggested that the process of atherosclerosis is accelerated and inhibited by MCSF and TGF-beta, respectively, The present results thus suggest that the alterations in the plasma levels of MCSF and TGF-beta may be involved in the pathogenesis of IHD in humans,
引用
收藏
页码:143 / 147
页数:5
相关论文
共 50 条
  • [21] Plasma lipids oxidizeability in patients with occlusive atherosclerosis of lower extremities and ischemic heart disease
    Dadvani, IA
    Syrkin, AL
    Azizova, OA
    Shcherbyuk, AN
    Dumikyan, AS
    Artyukhina, EG
    Ulyanov, DA
    Solovieva, NP
    Dudnik, LB
    KARDIOLOGIYA, 2005, 45 (04) : 55 - 60
  • [22] Lipoprotein (a) and ischemic heart disease in patients with hypertensive disease
    Britareva, VV
    Afanasieva, OI
    Dobrovolsky, AB
    Titaeva, EV
    Karpov, YA
    Pokrovsky, SN
    KARDIOLOGIYA, 2002, 42 (05) : 4 - 8
  • [23] Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease
    Jafarzadeh, Abdollah
    Esmaeeli-Nadimi, Ali
    Nough, Hossain
    Nemati, Maryam
    Rezayati, Mohammad Taghi
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2009, 9 (02): : 75 - 83
  • [24] Circulating levels of resistin, IL-6 and lipid profile in elderly patients with ischemic heart disease with and without diabetes
    Yaseen, Faisal
    Jaleel, Anila
    Aftab, Jawed
    Zuberi, Adnan
    Alam, Ejaz
    BIOMARKERS IN MEDICINE, 2012, 6 (01) : 97 - 102
  • [25] Ischemic heart disease and rheumatoid arthritis: Do inflammatory cytokines have a role?
    El Bakry, Samah A.
    Fayez, Dalia
    Morad, Caroline S.
    Abdel-Salam, Ahmed Mohamed
    Abdel-Salam, Zeinab
    ElKabarity, Rania H.
    El Dakrony, Al Hussein M.
    CYTOKINE, 2017, 96 : 228 - 233
  • [26] Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease
    Polzin, Amin
    Piayda, Kerstin
    Keul, Petra
    Dannenberg, Lisa
    Mohring, Annemarie
    Graeler, Markus
    Zeus, Tobias
    Kelm, Malte
    Levkau, Bodo
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 110 : 35 - 37
  • [27] Management of Hypertension in Patients with Ischemic Heart Disease
    Brian B. Agbor-Etang
    John F. Setaro
    Current Cardiology Reports, 2015, 17
  • [28] Assessment and management of patients with ischemic heart disease
    Akhtar, S
    Silverman, DG
    CRITICAL CARE MEDICINE, 2004, 32 (04) : S126 - S136
  • [29] COGNITIVE DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
    Yeremina, O. V.
    Petrova, M. M.
    Prokopenko, S. V.
    Isaeva, N. V.
    Kaskaeva, D. S.
    BYULLETEN SIBIRSKOY MEDITSINY, 2014, 13 (06): : 48 - U59
  • [30] Management of Hypertension in Patients with Ischemic Heart Disease
    Agbor-Etang, Brian B.
    Setaro, John F.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (12)